Dal Alert!

Receive alerts from Dalhousie by text message.

X

» Go to news main

Heidelberg Engineering pledges continued support for glaucoma research

Posted by Christena Copeland on March 1, 2018 in News
Left to right: DMRF CEO Brian Thompson; Dalhousie Faculty of Medicine Dean Dr. David Anderson; Heidelberg EngineeringDirector of Clinical Research Ali Tafreshi; Heidelberg Engineering Clinical Research Project Manager Dr. Sebastian Rausch; Heidelberg Engineering General Manager, USA, Ram Liebenthal; Dalhousie Research Director of the Department of Ophthalmology & Visual Sciences Dr. Balwantray Chauhan; Dalhousie President Dr. Richard Florizone.
Left to right: DMRF CEO Brian Thompson; Dalhousie Faculty of Medicine Dean Dr. David Anderson; Heidelberg EngineeringDirector of Clinical Research Ali Tafreshi; Heidelberg Engineering Clinical Research Project Manager Dr. Sebastian Rausch; Heidelberg Engineering General Manager, USA, Ram Liebenthal; Dalhousie Research Director of the Department of Ophthalmology & Visual Sciences Dr. Balwantray Chauhan; Dalhousie President Dr. Richard Florizone.

 

A well-defined vision is an essential aspect of any successful business and Heidelberg Engineering illustrates this on all fronts.  

A high-tech imaging solutions company that designs, manufactures, and distributes diagnostic instruments for eye care professionals, Heidelberg Engineering is headquartered in Germany, with offices around the globe.

Understanding the importance of healthy vision, Heidelberg Engineering’s products are used by ophthalmologists and optometrists to scan patients’ eyes for signs of disease and to assist in the management of patients found to have this disease. Early recognition of disease helps to delay and prevent the most common causes of blindness. This commitment to business excellence and visual wellness drove a steadfast desire to invest in ophthalmological research.  

Read more on Dal News.